Table 2 Clinical characteristics of the patients in the training and testing sets
Characteristics | Training set (n = 61) | Testing set (n = 33) | p value |
|---|---|---|---|
Age (years)* | 52 ± 9 (29–71) | 53 ± 11 (29–74) | 0.720 |
Menarche age (years)* | 14 ± 2 (10–20) | 14 ± 1 (13–17) | 0.425 |
Tumor size (mm)* | 53 ± 21 (24–120) | 52 ± 13 (35–79) | 0.848 |
Histological type | 0.708 | ||
SCC | 55 (90) | 31 (94) | |
ACA | 6 (10) | 2 (6) | |
Menopause | 0.730 | ||
Yes | 31 (51) | 15 (45) | |
No | 30 (49) | 18 (55) | |
Number of gestation | 0.226 | ||
≤ 3 | 32 (52) | 13 (39) | |
> 3 | 29 (48) | 20 (61) | |
Number of production | 0.474 | ||
≤ 3 | 50 (82) | 25 (76) | |
> 3 | 11 (18) | 8 (24) | |
Number of abortion | 0.206 | ||
≤ 3 | 54 (89) | 26 (79) | |
> 3 | 7 (11) | 7 (21) | |
FIGO stage | 0.215 | ||
IB | 16 (26) | 6 (18) | |
IIA | 12 (20) | 8 (24) | |
IIB | 13 (21) | 6 (18) | |
III | 15 (25) | 5 (16) | |
IV | 5 (8) | 8 (24) |